Osteoporosis, Postmenopausal
Pipeline by Development Stage
Drug Modality Breakdown
On Market (5)
Approved therapies currently available
Competitive Landscape
6 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (15)
Total enrollment: 5,976 patients across 15 trials
Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone
SOLID-Effect of Risedronate Sodium at Distal Radius in Colle's Fracture.
A Study to Determine the Satisfaction With Actonel in Postmenopausal Women With Osteoporosis
Satisfaction and Compliance of Risedronate in PMO
POWER Point of Care Effect on Satisfaction of Treatment
Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis
Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis
Multicenter Study in Postmenopausal Women With Osteoporosis, ALVOBOND
Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption
A Study of Blosozumab (LY2541546) in Postmenopausal Female Participants
Real-world Effectiveness and Cardiovascular Safety Study of Abaloparatide in Postmenopausal Women
Wellnara Post-marketing Surveillance in Japan
Julina Post-marketing Surveillance for Postmenopausal Osteoporosis in Japan
Julina Post-marketing Surveillance for Climacteric Symptoms in Japan
A Study for Teriparatide in Severe Osteoporosis